Get 40% Off
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off

Praxis Precision Medicines Inc (PRAX)

NASDAQ
Currency in USD
Disclaimer
54.71
+5.17(+10.44%)
Closed
After Hours
55.86+1.15(+2.10%)
Trading near 52-week High
Day's Range
50.4756.06
52 wk Range
11.8556.06
Prev. Close
49.54
Open
50.47
Day's Range
50.47-56.06
52 wk Range
11.85-56.06
Volume
160,780
Average Volume (3m)
145,451
1-Year Change
265.95%
Shares Outstanding
12,364,795
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
125.80
Upside +129.94%

People Also Watch

27.97
AMAM
-0.04%
10.790
FUSN
-10.01%
22.280
JSPR
+0.91%
27.71
DYN
-4.87%
28.74
FDMT
-2.15%
How do you feel today about PRAX?
Vote to see community's results!
or

Praxis Precision Medicines Inc Company Profile

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. It is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. The Company is applying genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally precision therapies; and Solidus, is an antisense oligonucleotide (ASO) platform, which targets precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include PRAX-944, PRAX-562, PRAX-628 and PRAX-222.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.